REFERENCES
- Suzuki H, Isaka M, Suzuki S. Type 1 diabetes mellitus associated with Graves’ disease and Vogt-Koyanagi-Harada syndrome. Intern Med. 2008;47(13):1241–1244.
- Al Hemidan Al, Tabbara, KF, Althomali T. Vogt-Koyanagi-Harada associated with diabetes mellitus and celiac disease in a 3-year-old girl. Eur J Ophthalmol. 2006;16(1):173–177.
- Maruyama Y, Hayashi H, Takahashi K, et al. A case of insulin dependant diabetes mellitus following systemic treatment for Vogt-Koyanagi-Harada syndrome. Ophthalmic Surg Lasers. 2000;31(6):487–490.
- Kluger N, Mura F, Guillot B, Bessis D. Vogt-Koyanagi-Harada syndrome associated with psoriasis and autoimmune thyroid disease. Acta Derm Venereol. 2008;88(4):397–398.
- Futagami Y, Sugita S, Fujimaki T, et al. Bilateral anterior granulomatous keratouveitis with sunset glow fundus in a patient with autoimmune polyglandular syndrome. Ocul Immunol Inflamm. 2009;17(2):88–90.
- Al-Halafi A, Dhibi HA, Hamade IH, Bou Chacra CT, Tabbara KF. The association of systemic disorders with Vogt-Koyanagi-Harada and sympathetic ophthalmia. Graefes Arch Clin Exp Ophthalmol. 2011;249:1229–1233.
- Fang W, Yang P. Vogt-Koyanagi-Harada syndrome. Curr Eye Res. 2008;33:517–523.
- Gorodezky C, Alaez C, Murguía A, et al. HLA and autoimmune diseases: type 1 diabetes (T1D) as an example. Autoimmun Rev. 2006;5:187–194.
- Bugawan TL, Klitz W, Alejandrino M, et al. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos. Tissue Antigens. 2002;59:452–469.
- Jin Y, Mailloux CM, Gowan K, et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med. 2007; 356: 1216–1225.
- Cağdaş DN, Paç FA, Cakal E. Glucocorticoid-induced diabetic ketoacidosis in acute rheumatic fever. J Cardiovasc Pharmacol Ther. 2008;13:298–300.
- Cakir M, Cekic¸ O, Yilmaz OF. Combined intravitreal bevacizumab and triamcinolone injection in a child with Coats disease. J AAPOS. 2008;12:309–311.
- Cakir M, Cekic¸ O, Yilmaz OF. Intravitreal bevacizumab and triamcinolone treatment for choroidal neovascularization in Best disease. J AAPOS. 2009;13:94–96.
- Cakir M, Cekic¸ O, Yilmaz OF. Intravitreal bevacizumab for idiopathic choroidal neovascularization. J AAPOS. 2009;13:296–298.
- Avery RL. Extrapolating anti-vascular endothelial growth factor therapy into pediatric ophthalmology: promise and concern. J AAPOS. 2009;13:329–331.
- Lott MN, Schiffman JC, Davis JL. Bevacizumab in inflammatory eye disease. Am J Ophthalmol. 2009;148:711–717.
- Conway MD, Peyman GA, Recasens M. Intravitreal tPA and SF6 promote clearing of premacular subhyaloid hemorrhages in shaken and battered baby syndrome. Ophthalmic Surg Lasers. 1999;30:435–441.